Get started
EXELIXIS INCEXELIXIS INCEXELIXIS INC

EXELIXIS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast

1EXEL chart


Full chart

1EXEL upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.66 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
22.60
Basic EPS (TTM)
1.75 EUR
Net income (FY)
‪503.53 M‬ EUR
Revenue (FY)
‪2.09 B‬ EUR
Shares float
‪266.47 M‬
Beta (1Y)
0.30

Employees


Employees (FY)
‪1.15 K‬
Change (1Y)
−163 −12.44%
Revenue / Employee (1Y)
‪1.83 M‬ EUR
Net income / Employee (1Y)
‪439.00 K‬ EUR

About Exelixis, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Michael M. Morrissey
Website
exelixis.com
Headquarters
Alameda
Founded
1994
FIGI
BBG01TNXQNJ8
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1EXEL news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Sparks


Curated watchlists where 1EXEL is featured.

See all sparks 


Check out other big names from the same industry as 1EXEL.

Frequently Asked Questions


The current price of 1EXEL is 32.56 EUR — it has decreased by −2.98% in the past 24 hours. Watch EXELIXIS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange EXELIXIS INC stocks are traded under the ticker 1EXEL.
1EXEL stock has risen by 0.92% compared to the previous week, the month change is a 3.95% rise, over the last year EXELIXIS INC has showed a −0.97% decrease.
We've gathered analysts' opinions on EXELIXIS INC future price: according to them, 1EXEL price has a max estimate of 39.41 EUR and a min estimate of 25.39 EUR. Watch 1EXEL chart and read a more detailed EXELIXIS INC stock forecast: see what analysts think of EXELIXIS INC and suggest that you do with its stocks.
1EXEL reached its all-time high on May 2, 2025 with the price of 34.47 EUR, and its all-time low was 32.88 EUR and was reached on Apr 25, 2025. View more price dynamics on 1EXEL chart.
See other stocks reaching their highest and lowest prices.
1EXEL stock is 4.98% volatile and has beta coefficient of 0.30. Track EXELIXIS INC stock price on the chart and check out the list of the most volatile stocks — is EXELIXIS INC there?
Today EXELIXIS INC has the market capitalization of ‪8.93 B‬, it has increased by 4.23% over the last week.
Yes, you can track EXELIXIS INC financials in yearly and quarterly reports right on TradingView.
EXELIXIS INC is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
1EXEL earnings for the last quarter are 0.46 EUR per share, whereas the estimation was 0.41 EUR resulting in a 12.81% surprise. The estimated earnings for the next quarter are 0.34 EUR per share. See more details about EXELIXIS INC earnings.
EXELIXIS INC revenue for the last quarter amounts to ‪547.47 M‬ EUR, despite the estimated figure of ‪545.23 M‬ EUR. In the next quarter, revenue is expected to reach ‪461.80 M‬ EUR.
1EXEL net income for the last quarter is ‪135.10 M‬ EUR, while the quarter before that showed ‪105.96 M‬ EUR of net income which accounts for 27.51% change. Track more EXELIXIS INC financial stats to get the full picture.
No, 1EXEL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 7, 2025, the company has ‪1.15 K‬ employees. See our rating of the largest employees — is EXELIXIS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXELIXIS INC EBITDA is ‪694.30 M‬ EUR, and current EBITDA margin is 33.14%. See more stats in EXELIXIS INC financial statements.
Like other stocks, 1EXEL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXELIXIS INC stock right from TradingView charts — choose your broker and connect to your account.